mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.001 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.002 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.002 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.002 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.002 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |